FindTrial
Sign In

A Randomised Trial Comparing External Beam Radiotherapy Alone With External Beam Radiotherapy Plus Intraluminal Irradiation for Palliation in Lung Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN83218866
Enrollment
Unknown
Registered
2002-08-19
Start date
2000-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung (non-small cell) cancer Cancer Lung (non-small cell)

Interventions

1. Schedule A: External beam radiotherapy, a maximum subcutaneous dose of 3250 cGy given in eight fractions over 10 days with a margin of 2 cm around the tumour. 2. Schedule B: External beam radioth

Sponsors

UK Co-ordinating Committee for Cancer Research (UKCCCR)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Biopsy proven non-small cell lung cancer 2. Fit to receive bronchoscopy 3. Fit to receive external beam radiotherapy 4. Any age 5. Shortness of breath, cough, haemoptysis, dysphagia or chest pain resulting from a primary bronchial tumour 6. No previous or concomitant malignancy, except basal cell carcinomas 7. No symptomatic metastases requiring external beam radiotherapy 8. No previous chest irradiation for lung cancer 9. No bilateral lung tumours or tracheal tumours

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026